44 results on '"Viktor Eret"'
Search Results
2. The predictive value of PHI versus PIRADS in mpMRI targeted prostate biopsy
3. Prostate health index as a predictor of significant prostate cancer
4. Papillary renal cell carcinoma type 1 differs substantially from other papillary tumours
5. The impact of prostate specific antigen density and prostate health index assessment for prediction of prostate cancer in prostate biopsy
6. PHI (Prostate Health Index) as a predictor of positive biopsy in prostate cancer: Results from multicentric study
7. PET/MRI in prostate cancer
8. Impact of renal anatomy on flexible ureterorenoscopy with holmium laser lithotripsy. Outcomes for lower pole kidney stones
9. PHI (prostate health index) – comparison with results of radical prostatectomy in two years period
10. The efficacy of flexible ureterorenoscopy versus shock wave lithotripsy for small lower caliceal calculus (≤1 cm)
11. The role of biopsy naive 3-T multiparametric MRI and preoperative assessment of prostate cancer
12. Surgical treatment of kidney tumours – contemporary trends in clinical practise
13. C10 Position of LESS (Laparoendoscopic Single-site Surgery) nephrectomy in clinical practice and comparison with standard laparoscopic nephrectomy
14. C03 MiT translocation renal cell carcinoma – A subset of tumours with translocation 6p21 [t(6;11)] or Xp11.2 [t(X;1 or X or 17)]
15. C01 Spindle and cuboidal renal cell carcinoma: Clinical results and long term follow up
16. C94 18F-fluorocholine (FCH) PET/CT for prostate cancer imaging – comparison of our cohort and literature data
17. C93 Comparison of 3T MRI of the prostate and prostate cancer specimens after radical prostatectomy by using the whole – mount sections technique
18. C20: Correlation of pathological grading and staging of the prostate cancer with the prostate health index
19. C137: Transperitoneal LESS (Laparoendoscopic Single- site Surgery) adrenalectomy (AE) - matched case-control study with standard laparoscopic adrenalectomy (SLAE)
20. C149: Optimal management of renal angiomyolipomas, our experience in 10 years series
21. C151: Typical signs of papillary renal cell carcinoma type 1 - typical spherical shape, exophytic growth and low histological grade
22. C113 LAPAROSCOPIC NEPHROPEXIS – TECHNIQUE WITH THRE NON-ABSORBABLE STITCHES
23. UP-1.123: Expression of Dd3/Pca3 mRNA in Tissue at Patients with Prostate Cancer and Benign Prostate Hyperplasia
24. UP.17: A Distinctive Translocation Carcinoma of the Kidney ('Rosette Forming', T(6;11), Hmb45 Positive)
25. UP.78: Dd3/Pca3 (Differential Display Code 3) in Prostate Cancer Diagnosis: Experience From Czech Republic
26. UP.20: Green Light (532 NM) Laser Partial Nephrectomy Followed by the Suture of the Collecting System Without Renal Hilar Clamping in a Porcine Model
27. MP-11.10: DD3/PCA3 (differential display code 3) in prostate cancer diagnosis – first data from Czech Republic
28. C128 PREOPERATIVE ASSESSMENT OF THE VASCULAR SUPPLY IN RENAL TUMOURS BY THREE TESLA MRI BIPHASIC ANGIOGRAPHY
29. C187 MULTIPARAMETRIC 3T MRI IMAGING OF PROSTATE CANCER IN CORRELATION WITH PROSTATECTOMY WHOLE-MOUNT SPECIMENS
30. C178 18F-FLUOROCHOLINE (FCH) PET/CT FOR PROSTATE CANCER PREOPERATIVE DIAGNOSIS – OUR FIRST EXPERIENCE
31. 924 Three Tesla MRI biphasic angiography is applicable method for preoperative assessment of vascular supply in renal tumour surgery
32. C3 IS PRO PSA MORE CANCER SPECIFIC FORM OF PROSTATE SPECIFIC ANTIGEN FOR THE EARLY DETECTION OF PROSTATE CANCER?
33. C120 UPER URINARY TRACT UROTHELIAL CARCINOMA IN END-STAGE KIDNEY
34. C171 ONCOCYTIC PAPILLARY RENAL CELL CARCINOMA IN CLINICAL PRAXIS
35. UP-1.68: Results of patients' questionnaires after photoselective vaporisation of the prostate: single institution survey
36. UP-1.125: Importance of miRNAs Expression in Prostate Cancer and Benign Prostate Tissue
37. UP-1.124: Chromogranin A in Hormone Independent Prostate Cancer
38. UP-2.083: Clinical Characteristic of Oncocytic Papillary Renal Cell Carcinoma
39. C1 The short-term results of transurethral vaporization of the prostate using plasmakinetic energy – first experience from Czech Republic
40. C104 Laparoscopic nephrectomy for advanced renal tumours (cT2>8cm, cT3a−b, cN+)
41. C51 Nephron sparing surgery for renal cancer – expanding indications and advancement in minimal invasive surgery
42. MP-6.11: Antegrade Mini-invasive Nephroureterectomy (AMNUE-Laparoscopic Nephrectomy, Transurethral Excision of Ureterovesical Junction and Lower Abdomen Incision)
43. 855 PAPILLARY RENAL CELL CARCINOMA ARE TREATED MORE FREQUENTLY BY LAPAROSCOPIC PARTIAL NEPHRECTOMY DUE TO THEIR EXOPHYTIC GROWTH THAN NON-PAPILLARY TUMOURS
44. V-03.12
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.